PMID- 31897412
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220412
IS  - 2325-9671 (Print)
IS  - 2325-9671 (Electronic)
IS  - 2325-9671 (Linking)
VI  - 7
IP  - 12
DP  - 2019 Dec
TI  - Patient-Reported Knee Outcome Scores With Soft Tissue Quadriceps Tendon Autograft 
      Are Similar to Bone-Patellar Tendon-Bone Autograft at Minimum 2-Year Follow-up: A 
      Retrospective Single-Center Cohort Study in Primary Anterior Cruciate Ligament 
      Reconstruction Surgery.
PG  - 2325967119890063
LID - 10.1177/2325967119890063 [doi]
LID - 2325967119890063
AB  - BACKGROUND: Quadriceps tendon (QT)-bone autografts used during anterior cruciate 
      ligament (ACL) reconstruction have provided comparable outcomes and decreased 
      donor-site morbidity when compared with bone-patellar tendon-bone (BPTB) 
      autografts. No study has directly compared the outcomes of the all-soft tissue QT 
      autograft with that of the BPTB autograft. HYPOTHESIS: Patient-reported knee 
      outcome scores and rates of postoperative complication after primary ACL 
      reconstruction with QT autografts are no different from BPTB autografts at a 
      minimum 2-year follow-up. STUDY DESIGN: Cohort study; Level of evidence, 3. 
      METHODS: A total of 75 patients who underwent primary autograft ACL 
      reconstruction with QT or BPTB autografts between January 1, 2015, and March 31, 
      2016, at a single hospital center were contacted by telephone and asked to 
      complete the International Knee Documentation Committee (IKDC) Subjective Knee 
      Evaluation, Tegner activity level scale, and Lysholm knee scoring scale. 
      Information about the subsequent surgeries performed on the operative knee was 
      also collected. Statistical analysis was performed using the Kruskal-Wallis test 
      and the Fisher exact test for categorical data. RESULTS: Fifty patients (28 QT, 
      22 BPTB) completed the surveys at a mean follow-up of 33.04 months (range, 24-44 
      months). For the QT versus the BPTB group respectively, the median IKDC scores 
      were 94.83 (interquartile range [IQR], 7.61) versus 94.83 (IQR, 10.92) (P = .47), 
      the median Tegner scores were 6 (IQR, 2.5) versus 6 (IQR, 2.75) (P = .48), and 
      the median Lysholm scores were 95 (IQR, 9) versus 95 (IQR, 13) (P = .27). 
      Additionally, 2 QT patients and 3 BPTB patients required follow-up arthroscopy 
      for arthrolysis (P = .64). There was 1 graft failure in the QT group requiring 
      revision surgery. CONCLUSION: There was no statistical difference in 
      patient-reported knee outcomes or graft complication rates between the QT and 
      BPTB autograft groups at a minimum 2-year follow-up after primary ACL 
      reconstruction. This study highlights that the all-soft tissue QT autograft may 
      be a suitable graft choice for primary ACL reconstruction.
CI  - (c) The Author(s) 2019.
FAU - Perez, Jose R
AU  - Perez JR
AD  - University of Miami Sports Medicine Institute, Coral Gables, Florida, USA.
FAU - Emerson, Christopher P
AU  - Emerson CP
AD  - University of Miami Sports Medicine Institute, Coral Gables, Florida, USA.
FAU - Barrera, Carlos M
AU  - Barrera CM
AD  - University of Miami Sports Medicine Institute, Coral Gables, Florida, USA.
FAU - Greif, Dylan N
AU  - Greif DN
AD  - University of Miami Sports Medicine Institute, Coral Gables, Florida, USA.
FAU - Cade, William H 2nd
AU  - Cade WH 2nd
AD  - University of Miami Sports Medicine Institute, Coral Gables, Florida, USA.
FAU - Kaplan, Lee D
AU  - Kaplan LD
AD  - University of Miami Sports Medicine Institute, Coral Gables, Florida, USA.
FAU - Baraga, Michael G
AU  - Baraga MG
AD  - University of Miami Sports Medicine Institute, Coral Gables, Florida, USA.
LA  - eng
PT  - Journal Article
DEP - 20191217
PL  - United States
TA  - Orthop J Sports Med
JT  - Orthopaedic journal of sports medicine
JID - 101620522
PMC - PMC6918041
OTO - NOTNLM
OT  - all-soft tissue quadriceps tendon autograft
OT  - anterior cruciate ligament reconstruction
OT  - bone-patellar tendon-bone autograft
OT  - quad tendon anterior cruciate ligament
COIS- One or more of the authors has declared the following potential conflict of 
      interest or source of funding: L.D.K. has received royalties from Arthrex and 
      Smith & Nephew and speaking fees from Arthrex. M.G.B. has received educational 
      support from Arthrex and Smith & Nephew and consulting fees from Arthrex and 
      LifeNet Health. AOSSM checks author disclosures against the Open Payments 
      Database (OPD). AOSSM has not conducted an independent investigation on the OPD 
      and disclaims any liability or responsibility relating thereto.
EDAT- 2020/01/04 06:00
MHDA- 2020/01/04 06:01
PMCR- 2019/12/17
CRDT- 2020/01/04 06:00
PHST- 2020/01/04 06:00 [entrez]
PHST- 2020/01/04 06:00 [pubmed]
PHST- 2020/01/04 06:01 [medline]
PHST- 2019/12/17 00:00 [pmc-release]
AID - 10.1177_2325967119890063 [pii]
AID - 10.1177/2325967119890063 [doi]
PST - epublish
SO  - Orthop J Sports Med. 2019 Dec 17;7(12):2325967119890063. doi: 
      10.1177/2325967119890063. eCollection 2019 Dec.